Main

id

1845217

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-01 02:44:57

expired found date

-

created at

2024-05-28 06:12:40

updated at

2026-02-07 11:04:31

Domain name statistics

length

18

crc

37348

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

256482523

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

1

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

2025-06-07 17:41:51

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

204520

mp size raw text

3455

mp inner links count

1

mp inner links status

20 (imported)

Open Graph

title

Home - EyePoint Pharmaceuticals

description

EyePoint Pharmaceuticals, Inc., is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders.

site name

EyePoint Pharmaceuticals

author

updated

2025-12-05 22:00:33

raw text

Home - EyePoint Pharmaceuticals Skip to content Contact Us About Leadership Board of Directors Scientific Advisory Board Science & Tech Vorolanib DURASERT® Technology VERISOME® Technology Partnerships and BD Initiatives Pipeline & Data Pipeline EYP-1901 Overview Clinical Trials Scientific Publications and Presentations EYP-2301 Investors Financial Information Financials Overview Stock Information Analyst Coverage Ownership Summary Annual Reports Earnings Releases SEC Filings Resources Press Releases Events & Presentations IR Contact Email Alerts Corporate Governance Governance Overview Management Team Board of Directors Committee Composition Contact the Board FAQs Form 8937 News Careers About Leadership Board of Directors Scientific Advisory Board Science & Tech Vorolanib DURASERT® Technology VERISOME® Technology Partnerships and BD Initiatives Pipeline & Data Pipeline EYP-1901 ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medycyna (36)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2672

text words

430

text unique words

154

text lines

145

text sentences

11

text paragraphs

3

text words per sentence

39

text matched phrases

3

text matched dictionaries

2

RSS

rss status

32 (unknown)

rss found date

2024-02-10 16:45:59

rss size orig

26504

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)

sitemap review version

2

sitemap urls count

808

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

9

sitemap found date

2024-02-09 19:40:21

sitemap process date

2025-08-01 11:18:15

sitemap first import date

-

sitemap last import date

2026-02-07 11:04:31